Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon?

@article{Cremon2010IntestinalDI,
  title={Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon?},
  author={Cesare Cremon and Giovanni Carini and Roberto De Giorgio and Vincenzo Stanghellini and Roberto Corinaldesi and Giovanni Barbara},
  journal={Expert Review of Molecular Diagnostics},
  year={2010},
  volume={10},
  pages={389 - 393}
}
  • Cesare Cremon, Giovanni Carini, +3 authors Giovanni Barbara
  • Published 2010
  • Biology, Medicine
  • Expert Review of Molecular Diagnostics
  • Evaluation of: Lyra A, Rinttilä T, Nikkilä J et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J. Gastroenterol. 15(47), 5936–5945 (2009). Irritable bowel syndrome (IBS) is a functional disorder of multifactorial origin. Recent interest has been directed to the potential role of intestinal microbiota in the pathophysiology and symptom generation of this syndrome. This hypothesis is supported by the evidence of an infectious… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The aim of the study is to collect data for the assessment of the Lactobacillus casei DG (Enterolactis plus®) effect on overall abdominal pain/discomfort, symptoms and gut microbiota… Expand
    ConditionsIrritable Bowel Syndrome
    InterventionDietary Supplement

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 23 CITATIONS, ESTIMATED 73% COVERAGE

    Probiotics in irritable bowel syndrome: Where are we?

    Commensal bacteria: the link between IBS and IBD?

    • E M M Quigley
    • Medicine, Biology
    • Current opinion in clinical nutrition and metabolic care
    • 2011

    FILTER CITATIONS BY YEAR

    2011
    2019

    CITATION STATISTICS

    • 1 Highly Influenced Citations

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 42 REFERENCES

    Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients.